Odom & Des Roches, LLP engages in multi-party litigation of complex civil matters throughout the United States. The firm’s clients include local businesses, national and international companies, and private individuals.

The lawyers of Odom & Des Roches, LLP have particular depth of experience in antitrust litigation, corporate litigation, financial transactions litigation, professional liability litigation, and pharmaceutical industry litigation. The firm maintains an active defense practice, and regularly represents an international accounting firm and other business interests. Several years ago the firm expanded its practice to represent plaintiffs in antitrust contingency fee class action and Multi-District Litigation matters, particularly in the pharmaceutical industry. In addition to its active jury trial practice, the firm has extensive appellate experience, and its senior partner argued and won the 9-0 reversal of a federal circuit court of appeals before the United States Supreme Court.

The core of the firm’s practice is its commitment and ability to try jury cases, and its lawyers structure their strategy from the outset of an engagement with an eye towards eventual appearance in the courtroom. It is the firm’s philosophy and experience that being prepared for the rigors of trial maximizes the opportunities for the client to obtain favorable results.

The firm has been actively involved in the following national antitrust class action and non-class action cases:

• In re Buspirone Antitrust Litig., MDL Docket No. 1410, U.S.D.C., S.D.N.Y. (district court appointment to steering committee representing Sherman Act Class Plaintiffs) (district court approved settlement of $220,000,000).
• In re Cardizem CD Antitrust Litig., MDL Docket No. 1278, U.S.D.C., E.D.Mich. (district court appointment to discovery committee representing Sherman Act Class Plaintiffs) (district court approved settlement of $110,000,000).
• In re Relafen Antitrust Litig., Master File No. 01-12239, U.S.D.C., D.Mass. (district court approved settlement of $175,000,000).
• In re Brand Name Prescription Drugs Antitrust Litig., No. 94 C 897, U.S.D.C., E.D.N.Y. (representation of 3,800 non-class independent retail pharmacy operations) (private settlements reached with many defendants).
• In re Terazosin Hydrochloride Antitrust Litig., MDL Docket No. 1317, U.S.D.C., S.D. Fla. (counsel for Sherman Act Plaintiffs) (district court approved settlement of $72,500,000).
• In re Remeron Antitrust Litig., 03-CV-0085, U.S.D.C., D.N.J. (counsel for Sherman Act Plaintiffs) (district court approved settlement of $75,000,000).
• In re K-Dur Antitrust Litig., MDL Docket No. 1419, U.S.D.C., D.N.J. (district court appointment to executive committee representing Sherman Act Class Plaintiffs).
• In re Ciprofloxacin Hydrochloride Antitrust Litig., 00-MDL-1383, U.S.D.C., E.D.N.Y. (district court appointment to executive committee representing Sherman Act Class Plaintiffs).
• In re TriCor Direct Purchaser Antitrust Litig., Civil Action No. 05-340, U.S.D.C., D. Del.
• In re Northwest Airlines Corp., et al., Antitrust Litig., Master File No. 96-74711, U.S.D.C., E.D.Mich.
• In re Oxycontin Antitrust Litig., Civil Action No. 1:04-CV-00229-SHS, U.S.D.C., S.D.N.Y.
• Louisiana Wholesale Drug Company, Inc. v. Biovail Corp. and Forest Laboratories, Inc., Civil Action No. 04-cov-2235 (JR), U.S.D.C., D.D.C.
• In re Hypodermic Direct Purchaser Antitrust Litig., Civil Action No. 05-1602 (JLL), U.S.D.C., D.N.J. (district court appointment to executive committee representing Sherman Act Class Plaintiffs).
• Texas Grain Storage, Inc. v. Monsanto Company, Civil Action No. SA-07-CA-673-OG, U.S. D.C. W.D.Tex.
• Natchitoches Parish Hospital Service District et al v. Tyco International (US) et al, No. 05-cv-12024 (PBS), U.S.D.C., D. Mass
• In re Mushroom Direct Purchaser Antitrust Litig., Master File No. 06-cv-0620 (TON), U.S.D.C., E.D. Pa.
• Louisiana Wholesale Drug Co., Inc. v. Sanofi-Aventis, et al., U.S.D.C., S.D.N.Y., Case No. 07 CV 7343
• Louisiana Wholesale Drug Co., Inc. v. Abbott Laboratories, U.S.D.C., N.D. Cal., No. C 07-06118
• J.D.B.L. Corp., et al. V. Wyeth-Ayerst Laboratories, Inc., et al., U.S.D.C., S.D. Ohio, Case No. 05-3988
• In re Modafinil Antitrust Litigation, U.S.D.C., E.D. Pa., Civ. A. No. 06-1797
• Allied Orthopedic Appliances, Inc. v. Tyco Health Care Group L.P. et al., U.S.D.C., C.D. Cal., Master File No. CV 05-6419

Odom & Des Roches, LLP, which is rated "AV" by Martindale-Hubbell, maintains offices in New Orleans, Louisiana and Hahira, Georgia. The firm is listed in Martindale-Hubbell’s “Bar Register of Preeminent Lawyers”.